PEOPLE - Changes at JenaValve Technology:
This article was originally published in Clinica
Germany's JenaValve Technology has established a scientific advisory board, appointing eight members with immediate effect. It is headed by Professor Hans-Reiner Figulla, a cardiologist and co-founder and inventor at the Munich-based minimally-invasive aortic valve replacement systems developer. The other members are: fellow co-founder and inventor Dr Markus Ferrari; stent catheter consultant Dr Younes Boudjemline (Necker Hospital, Paris); Professor Junbo Ge, co-chair of the Shanghai Institute of Cardiovascular Diseases and president of the Shanghai Society of Cardiology; Professor Martin Rothman, director of cardiac R&D at London's Barts hospital; Professor Ziyad Hijazi, of Chicago's Rush University; Professor Jan Gummert, director of cardiothoracic surgery at Friedrich Schiller University Jena, Germany; and Professor Horst Sievert, director of the CardioVascular Center, Frankfurt.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.